Success Metrics

Clinical Success Rate
28.6%

Based on 2 completed trials

Completion Rate
29%(2/7)
Active Trials
1(10%)
Results Posted
50%(1 trials)
Terminated
5(50%)

Phase Distribution

Ph phase_1
4
40%
Ph phase_4
1
10%

Phase Distribution

4

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
4(80.0%)
Phase 4Post-market surveillance
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

28.6%

2 of 7 finished

Non-Completion Rate

71.4%

5 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(2)
Terminated(5)
Other(1)

Detailed Status

Terminated5
Completed2
unknown1
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
28.6%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (80.0%)
Phase 41 (20.0%)

Trials by Status

terminated550%
completed220%
unknown110%
recruiting110%
not_yet_recruiting110%

Recent Activity

1 active trials
Showing 5 of 10
recruitingphase_1

Imaging of Solid Tumors Using FAP-2286

NCT04621435
not_yet_recruitingphase_1

Application of ⁶⁸Ga-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases.

NCT07144085
completedphase_1

18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies

NCT02348749
terminatedphase_1

PET Imaging of Extrathalamic α4β2-nicotinic Acetylcholine Receptors in Health and Disease With [18F]XTRA

NCT01894646
unknown

Expanded Access Protocol of 68Ga-PSMA-11 for PET Imaging

NCT04348682
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT04621435Phase 1

Imaging of Solid Tumors Using FAP-2286

Recruiting
NCT07144085Phase 1

Application of ⁶⁸Ga-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases.

Not Yet Recruiting
NCT02348749Phase 1

18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies

Completed
NCT01894646Phase 1

PET Imaging of Extrathalamic α4β2-nicotinic Acetylcholine Receptors in Health and Disease With [18F]XTRA

Terminated
NCT04348682

Expanded Access Protocol of 68Ga-PSMA-11 for PET Imaging

Unknown
NCT01681849Phase 4

Neural Circuits in Women With Abuse and Posttraumatic Stress Disorder

Completed
NCT02237703

Kappa Opioid Receptor Imaging in Post-traumatic Stress Disorder (PTSD)

Terminated
NCT02236702

Kappa Opioid Receptor Imaging in Depression (KOR Depression)

Terminated
NCT02237677

CB1 Receptor PET Imaging Reveals Gender Differences in PTSD

Terminated
NCT02240797

Kappa Opioid Receptor Imaging in Anorexia

Terminated

All 10 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
10